| BSE: 539523 | Sector: Health care |
| NSE: ALKEM | ISIN Code: INE540L01014 |
| BSE 00:00 | 16 Aug | 1758.90 |
-8.40 (-0.48%) |
OPEN
1779.55 |
HIGH
1779.80 |
LOW
1754.15 |
| NSE 00:00 | 16 Aug | 1761.85 |
-5.35 (-0.30%) |
OPEN
1768.45 |
HIGH
1781.35 |
LOW
1754.95 |
| OPEN | 1779.55 |
| PREVIOUS CLOSE | 1767.30 |
| VOLUME | 147 |
| 52-Week high | 2265.00 |
| 52-Week low | 1660.35 |
| P/E | 23.87 |
| Mkt Cap.(Rs cr) | 21,028 |
| Buy Price | 1738.35 |
| Buy Qty | 1.00 |
| Sell Price | 1779.00 |
| Sell Qty | 1.00 |
Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics generic drugs active pharmaceutical ingredients (APIs) and nutraceuticals which it markets in India and international markets. Wi...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
21,028 | |
| EPS - TTM | () |
[*S] | 73.68 |
| P/E Ratio | (X) | [*S] | 23.87 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 400.00 | |
| Latest Dividend Date | 19 Aug 2019 | ||
| Dividend Yield | (%) | 0.91 | |
| Book Value / Share | () |
[*S] | 457.09 |
| P/B Ratio | () |
[*S] | 3.85 |
Announcement under Regulation 30 (LODR)-Investor Presentation
Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2019.
Alkem Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Particulars ( cr) |
Jun 2019 | Jun 2018 | % Chg |
| Net Sales | 1849.5 | 1658.94 | 11.49 |
| Other Income | 17.47 | 26.77 | -34.74 |
| Total Income | 1866.97 | 1685.71 | 10.75 |
| Total Expenses | 1585 | 1455.23 | 8.92 |
| Operating Profit | 281.97 | 230.48 | 22.34 |
| Net Profit | 187.29 | 137.27 | 36.44 |
| Equity Capital | 23.91 | 23.91 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Torrent Pharma. | 1647.20 | -2.64 | 27873.92 |
| Biocon | 227.80 | -1.98 | 27336.00 |
| Cadila Health. | 217.65 | -0.02 | 22280.83 |
| Alkem Lab | 1758.90 | -0.48 | 21027.65 |
| Glaxosmi. Pharma | 1213.20 | 0.49 | 20552.82 |
| Abbott India | 9136.30 | -0.32 | 19414.64 |
| Sanofi India | 6297.05 | 0.12 | 14502.11 |
|
|
|
| Date | Broker | Action | Price | Report |
| 29/11 | Motilal Oswal | Buy | 1968 |  Details |
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -0.31% | -0.04% | -0.62% | -0.56% |
| 1 Month | -1.10% | -0.83% | -4.55% | -5.27% |
| 3 Month | 4.52% | 4.45% | -0.12% | -1.86% |
| 6 Month | -2.45% | -1.94% | 4.30% | 3.02% |
| 1 Year | -13.76% | -13.78% | -0.83% | -2.96% |
| 3 Year | 13.67% | 14.29% | 33.09% | 27.83% |
| Today's Low/High | 1754.15 |
|
1779.80 |
| Week Low/High | 1705.10 |
|
1805.00 |
| Month Low/High | 1662.30 |
|
1836.00 |
| YEAR Low/High | 1660.35 |
|
2265.00 |
| All TIME Low/High | 1175.00 |
|
2468.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
